Print

Lay Description

The purpose of this study is to determine the safety and efficacy of nab-paclitaxel and gemcitabine with or without olaratumab in the treatment of first-line metastatic pancreatic cancer.

Category

  • Diabetes
  • Minority Studies
IRB Number
20150799HU
NCT Number
NCT # not yet entered

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact


Andrea Hansis-Diarte
210-567-3208
hansisdiarte@uthscsa.edu